Skip to content

A Novel/Common Approach for Temporalis Muscle Thickness Measurement

A Novel/Common Approach for Temporalis Muscle Thickness Measurement: Reliability and Agreement Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05456399
Enrollment
60
Registered
2022-07-13
Start date
2022-07-10
Completion date
2023-02-18
Last updated
2024-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sarcopenia, Stroke

Brief summary

The aim of this study is to propose a new measurement point for temporal muscle thickness (TMT) that can be similarly localized in computerized tomography (CT) /magnetic resonance imaging (MRI) and ultrasonography (USG), and to evaluate the reliability and consistency of these measurements.

Detailed description

Recently, temporal muscle thickness (TMT) has been proposed as a new marker of whole-body muscle function. In addition, TMT has been shown to be a useful parameter for estimating skeletal muscle mass. Measurement of temporal muscle mass with CT and MRI has been studied in the literature in recent years. All stroke patients undergo cranial CT or MRI examinations at the time of admission. However, the literature indicates that USG can also be used to measure temporal muscle thickness. The recommended measurement points for CT, MRI, or USG in the studies performed to date depend on the particular imaging modality, and it does not seem possible to use them interchangeably. The aim of this study is to propose a new TMT measurement point that can be localized in a similar way in CT /MRI and USG, and to evaluate the reliability and agreement of these measurements.

Interventions

None listed

Sponsors

Bozyaka Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Referral to the radiology department for an MRI or CT scan

Exclusion criteria

* Medically unstable condition (presence or high risk of impaired consciousness, respiration, or circulation). * Vulnerable populations (patients with a terminal illness, people living in nursing homes, unemployed or poor people, people in need of urgent medical care, children, people unable to consent, etc.).

Design outcomes

Primary

MeasureTime frameDescription
Intra-rater reliability of ultrasonographic TMT measurement.BaselineThe intraclass correlation coefficient (ICC) of the two measurements performed by the physiatrist will be calculated using the Two-way mixed effects, absolute agreement, single rater/measurement model.
Inter-rater reliability of ultrasonographic TMT measurement.BaselineIntraclass correlation coefficients of TMT measurements performed by the radiologist and physiatrist will be calculated using the Two-way mixed effects, absolute agreement, multiple raters/measurements model.
Inter-rater reliability of TMT measurements of MRI and CTBaselineIntraclass correlation coefficients of TMT measurements performed by the radiologist and physiatrist will be calculated using the Two-way mixed effects, absolute agreement, single rater/measurement model.
Agreement of ultrasonographic TMT measurement with MRI and CT measurements.BaselineThe intraclass correlation coefficient of the measurements will be calculated using the two-way mixed effects, absolute agreement, multiple raters/measurements model. In addition, the agreement of the measurements will be evaluated using the Bland-Altman method. Furthermore, the Technical Error of Measurement (TEM) will be calculated.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026